FibroBiologics says Australia accepts patent application for spinal disc cartilage regeneration cell blend
FBLG•FibroBiologics received an Australian Notice of Acceptance for a patent application covering a cell blend intended to regenerate cartilage in degenerated spinal discs. The application is expected to proceed to grant following publication.
1. Patent application accepted
The patent claims cover delivering fibroblasts with platelet-rich plasma, paired with nucleus pulposus components, to generate chondrocytes and repair disc cartilage. FibroBiologics said examination is complete and the application is expected to proceed to grant following publication.
